Minerva Neurosciences, Inc. (NERV) Financial Statements (2026 and earlier)
Company Profile
| Business Address |
1601 TRAPELO ROAD WALTHAM, MA 02451 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 6/30/2025 MRQ | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 21,362 | 40,913 | 36,094 | 60,755 | 25,357 | 45,854 | |||
| Cash and cash equivalent | 21,362 | 40,913 | 36,094 | 60,755 | 25,357 | 21,413 | |||
| Short-term investments | 24,442 | ||||||||
| Restricted cash and investments | 100 | 100 | 100 | 100 | 100 | 100 | |||
| Prepaid expense | 807 | 990 | 848 | 1,346 | 1,983 | 1,182 | |||
| Other undisclosed current assets | 3,117 | ||||||||
| Total current assets: | 22,269 | 42,002 | 40,159 | 62,201 | 27,440 | 47,137 | |||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 102 | 262 | |||||||
| Property, plant and equipment | 5 | 11 | 16 | 16 | |||||
| Intangible assets, net (including goodwill) | 14,869 | 14,869 | 14,869 | 14,869 | 30,069 | 30,069 | |||
| Goodwill | 14,869 | 14,869 | 14,869 | 14,869 | 14,869 | 14,869 | |||
| Intangible assets, net (excluding goodwill) | 15,200 | 15,200 | |||||||
| Other noncurrent assets | 15 | 15 | |||||||
| Other undisclosed noncurrent assets | 17 | 43 | 51 | ||||||
| Total noncurrent assets: | 14,875 | 14,897 | 14,928 | 14,920 | 30,186 | 30,362 | |||
| TOTAL ASSETS: | 37,144 | 56,900 | 55,087 | 77,122 | 57,626 | 77,499 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 2,485 | 2,563 | 1,098 | 1,916 | 1,137 | 2,631 | |||
| Accounts payable | 1,608 | 1,805 | 970 | 1,853 | 996 | 2,317 | |||
| Accrued liabilities | 877 | 757 | 128 | 63 | 141 | 314 | |||
| Debt | 173 | ||||||||
| Other undisclosed current liabilities | 352 | 778 | 279 | 903 | 2,024 | 3,825 | |||
| Total current liabilities: | 2,837 | 3,340 | 1,378 | 2,819 | 3,160 | 6,629 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation: | 111 | ||||||||
| Liabilities, other than long-term debt | 1,803 | 42,979 | |||||||
| Deferred revenue | 41,176 | ||||||||
| Deferred income tax liabilities | 1,803 | 1,803 | |||||||
| Operating lease, liability | 111 | ||||||||
| Other undisclosed noncurrent liabilities | 60,000 | 82,017 | 73,734 | 66,327 | |||||
| Total noncurrent liabilities: | 60,000 | 82,017 | 73,734 | 66,327 | 1,803 | 43,090 | |||
| Total liabilities: | 62,837 | 85,357 | 75,111 | 69,146 | 4,964 | 49,719 | |||
| Equity | |||||||||
| Equity, attributable to parent | (25,693) | (28,457) | (20,024) | 7,976 | 52,663 | 27,780 | |||
| Common stock | 1 | 1 | 1 | 4 | 4 | 4 | |||
| Additional paid in capital | 369,683 | 368,357 | 346,785 | 342,673 | 337,454 | 314,512 | |||
| Accumulated deficit | (395,377) | (396,815) | (366,810) | (334,701) | (284,795) | (286,736) | |||
| Total equity: | (25,693) | (28,457) | (20,024) | 7,976 | 52,663 | 27,780 | |||
| TOTAL LIABILITIES AND EQUITY: | 37,144 | 56,900 | 55,087 | 77,122 | 57,626 | 77,499 | |||
Income Statement (P&L) ($ in thousands)
| 6/30/2025 TTM | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 26,579 | 41,176 | ||||||
| Other income | 26,579 | |||||||
| Gross profit: | 26,579 | 41,176 | ||||||
| Operating expenses | (21,848) | (23,120) | (25,231) | (45,366) | (39,329) | (75,865) | ||
| Other undisclosed operating loss | (26,579) | |||||||
| Operating income (loss): | (21,848) | (23,120) | (25,231) | (45,366) | 1,847 | (75,865) | ||
| Nonoperating income (expense) | 1,270 | 1,397 | 529 | (16) | 94 | 1,427 | ||
| Investment income, nonoperating | 1,272 | 1,437 | 557 | 17 | 161 | 1,456 | ||
| Loss, foreign currency transaction, before tax | (2) | (40) | (28) | (33) | (67) | (29) | ||
| Income (loss) from continuing operations before equity method investments, income taxes: | (20,578) | (21,722) | (24,702) | (45,382) | 1,941 | (74,438) | ||
| Other undisclosed loss from continuing operations before income taxes | (7,407) | (6,327) | ||||||
| Income (loss) from continuing operations before income taxes: | (20,578) | (21,722) | (32,109) | (51,709) | 1,941 | (74,438) | ||
| Income tax benefit | 1,803 | 2,254 | ||||||
| Income (loss) from continuing operations: | (20,578) | (21,722) | (32,109) | (49,906) | 1,941 | (72,183) | ||
| Income (loss) before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | ✕ | (49,906) | 1,941 | (72,183) | |
| Other undisclosed net income (loss) | 22,017 | (8,283) | ||||||
| Net income (loss): | 1,439 | (30,005) | (32,109) | (49,906) | 1,941 | (72,183) | ||
| Other undisclosed net income attributable to parent | ||||||||
| Net income (loss) available to common stockholders, basic: | 1,439 | (30,005) | (32,109) | (49,906) | 1,941 | (72,183) | ||
| Other undisclosed net loss available to common stockholders, diluted | ||||||||
| Net income (loss) available to common stockholders, diluted: | 1,439 | (30,005) | (32,109) | (49,906) | 1,941 | (72,183) | ||
Comprehensive Income ($ in thousands)
| 6/30/2025 TTM | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | 1,439 | (30,005) | (32,109) | (49,906) | 1,941 | (72,183) | ||
| Comprehensive income (loss), net of tax, attributable to parent: | 1,439 | (30,005) | (32,109) | (49,906) | 1,941 | (72,183) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.